Saroglitazar for the treatment of NAFLD patients: a single-center observational study at 52 weeks follow up von Hajare, Santosh D., Ghorpade, Sandesha S.

Volltext

FRI091 - Saroglitazar for the treatment of NAFLD patients: a single-center observational study at 52 weeks follow up von Hajare, Santosh D., Ghorpade, Sandesha S.

Volltext

Efficacy analysis of different management regimens for metabolic dysfunction-associated steatotic liver disease - a 52 weeks, four-arms, single center, observational study von Ghorpade, Sandesha, Hajare, Santosh

Volltext

Incidence of Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH) in the Female Population of North Karnataka: A Cross-Sectional Study von Desai, Geeta S, Hajare, Santosh, Ghorpade, Sandesha

Volltext

Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) / Nonalcoholic Steatohepatitis (NASH) in General Population of North Karnataka von Desai, Geeta S., Hajare, Santosh, Kharde, Sangeeta, Ghorpade, Sandesha

Volltext

An Investigator Initiated Prospective, Single Arm Observational Study to Evaluate the Safety and Efficacy of Saroglitazar 4 mg in Patients with Non-Alcoholic Fatty Liver Disease (N... von Hajare, Santosh D, Gokak, Varadaraj P, Ghorpade, Sandesha, Patil, Amar, Jadhav, Arvind

Volltext